A Review of the Molecular Landscape of Adenoid Cystic Carcinoma of the Lacrimal Gland
SK Powell, K Kulakova, S Kennedy - International Journal of Molecular …, 2023 - mdpi.com
Adenoid cystic carcinoma (ACC) has a worldwide incidence of three to four cases per million
population. Although more cases occur in the minor and major salivary glands, it is the most …
population. Although more cases occur in the minor and major salivary glands, it is the most …
FNIII14 peptide-enriched membrane nanocarrier to disrupt stromal barriers through reversing CAFs for augmenting drug penetration in tumors
Z Liu, P Ji, H Liu, L Yu, SM Zhang, P Liu, XZ Zhang… - Nano Letters, 2023 - ACS Publications
Given the key roles of cancer associated fibroblasts (CAFs) in shaping tumor stroma, this
study shows a CAF-associated ITGB1-inactivating peptide-enriched membrane …
study shows a CAF-associated ITGB1-inactivating peptide-enriched membrane …
Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
L He, J Zhang, T Zhu, P Zhao, P Mou… - Cancer Medicine, 2024 - Wiley Online Library
Background Studies on the epidemiological information and prognosis of primary malignant
lacrimal gland tumors (MLGTs) are rare for its low occurrence. The goal of our research was …
lacrimal gland tumors (MLGTs) are rare for its low occurrence. The goal of our research was …
Apoptotic Marker Expression of Resected Lacrimal Gland Adenoid Cystic Carcinoma Tumor Margins After Intra-arterial Chemotherapy and Globe-Sparing Excision
MK Shoji, AHM Moeyersoms, Q Wang… - Ophthalmic Plastic & …, 2024 - journals.lww.com
Purpose: Lacrimal gland adenoid cystic carcinoma (LGACC) is a rare orbital malignancy
with devastating lethality. Neoadjuvant intra-arterial chemotherapy (IACC) has demonstrated …
with devastating lethality. Neoadjuvant intra-arterial chemotherapy (IACC) has demonstrated …
Tumor Immune Microenvironment in Adenoid Cystic Carcinoma of the Lacrimal Gland: Relationship with Histopathology and Prognosis
Y Zhang, J Sun, Y Bi, R Cai, R Zhang, H Ren, F Meng… - 2024 - researchsquare.com
Purpose: To quantitatively investigate the pathological subtypes of lacrimal gland adenoid
cystic carcinoma (LGACCs), the tumor immune microenvironment in each pathological …
cystic carcinoma (LGACCs), the tumor immune microenvironment in each pathological …
Long-Term Outcomes of Neoadjuvant IntraArterial Chemotherapy for Locally Invasive Lacrimal Gland Carcinoma ex Pleomorphic Adenoma
L Juratli, J Kim, S Juntipwong, VM Elner… - Ophthalmic Plastic & … - journals.lww.com
Purpose: There is no current standard treatment regimen for carcinoma ex pleomorphic
adenoma (CXPA) of the lacrimal gland. Neoadjuvant intraarterial cytoreductive …
adenoma (CXPA) of the lacrimal gland. Neoadjuvant intraarterial cytoreductive …
[HTML][HTML] Adenoid Cystic Carcinoma of the Lacrimal Gland
C Chaaya, G El Haddad, FA Karim… - Journal of Current …, 2024 - journals.lww.com
Purpose: To explore the various aspects of adenoid cystic carcinoma of the lacrimal gland
(LACC), including its clinical features, presentations, genetic factors, as well as current and …
(LACC), including its clinical features, presentations, genetic factors, as well as current and …